• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度城市地区糖尿病视网膜病变的发病率与进展:桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS II),报告1

Incidence and Progression of Diabetic Retinopathy in Urban India: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II), Report 1.

作者信息

Raman Rajiv, Ganesan Suganeswari, Pal Swakshyar Saumya, Gella Laxmi, Kulothungan Vaitheeswaran, Sharma Tarun

机构信息

a Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya , Chennai , Tamil Nadu , India.

b Elite School of Optometry, St. Thomas Mount , Chennai , Tamil Nadu , India.

出版信息

Ophthalmic Epidemiol. 2017 Oct;24(5):294-302. doi: 10.1080/09286586.2017.1290257. Epub 2017 Mar 23.

DOI:10.1080/09286586.2017.1290257
PMID:28332894
Abstract

PURPOSE

To evaluate the 4-year incidence and progression of and risk factors for diabetic retinopathy (DR) in an Indian population.

METHODS

From a cross-sectional study of 1425 subjects with diabetes, 911 (63.9%) returned for 4-year follow-up. After excluding 21 with ungradable retinal images, data from 890 subjects were analyzed. Participants underwent examinations based on a standard protocol, which included grading of retinal photographs.

RESULTS

The incidences of DR, diabetic macular edema (DME), and sight-threatening diabetic retinopathy (STDR) were 9.2%, 2.6%, and 5.0%, respectively. In subjects with DR at baseline, the incidence of DME and STDR had increased (11.5% and 22.7%, respectively). 1-step and 2-step progressions of DR were seen in 30.2% and 12.6% of participants, respectively, and 1-step and 2-step regressions were seen in 12.0% and 1.8%, respectively. Incident DR, DME, and STDR were associated with higher systolic blood pressure (odds ratio, OR, 1.21, 2.11 and 1.72, respectively, for every 10 mmHg increase). Incident DR and DME were associated with increasing duration of diabetes (OR 2.29 and 4.77, respectively, for every 10-year increase) and presence of anemia (OR 1.96 and 10.14, respectively). Incident DR was also associated with higher hemoglobin A1c (OR 1.16 for every 1% increase). Variables associated with 1-step progression were every 10 mg/dL increase in serum total cholesterol (OR 15.65) as a risk factor, and 10 mg/dL increase in serum triglyceride (OR 0.52) as a protective factor.

CONCLUSIONS

The incidences of STDR and DME were higher in people with pre-existing DR than in those without DR at baseline.

摘要

目的

评估印度人群中糖尿病视网膜病变(DR)的4年发病率、进展情况及危险因素。

方法

在一项对1425名糖尿病患者的横断面研究中,911名(63.9%)患者返回进行4年随访。排除21名视网膜图像无法分级的患者后,对890名患者的数据进行分析。参与者按照标准方案接受检查,其中包括对视网膜照片进行分级。

结果

DR、糖尿病性黄斑水肿(DME)和威胁视力的糖尿病视网膜病变(STDR)的发病率分别为9.2%、2.6%和5.0%。在基线时患有DR的患者中,DME和STDR的发病率有所上升(分别为11.5%和22.7%)。分别有30.2%和12.6%的参与者出现了DR的1级和2级进展,分别有12.0%和1.8%的参与者出现了1级和2级逆转。新发DR、DME和STDR与较高的收缩压相关(收缩压每升高10 mmHg,比值比分别为1.21、2.11和1.72)。新发DR和DME与糖尿病病程延长(病程每延长10年,比值比分别为2.29和4.77)及贫血的存在(比值比分别为1.96和10.14)相关。新发DR还与较高的糖化血红蛋白水平相关(糖化血红蛋白每升高1%,比值比为1.16)。与1级进展相关的变量包括血清总胆固醇每升高10 mg/dL作为危险因素(比值比为15.65),以及血清甘油三酯每升高10 mg/dL作为保护因素(比值比为0.52)。

结论

基线时已有DR的患者中,STDR和DME的发病率高于无DR的患者。

相似文献

1
Incidence and Progression of Diabetic Retinopathy in Urban India: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II), Report 1.印度城市地区糖尿病视网膜病变的发病率与进展:桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS II),报告1
Ophthalmic Epidemiol. 2017 Oct;24(5):294-302. doi: 10.1080/09286586.2017.1290257. Epub 2017 Mar 23.
2
Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathy.糖尿病视网膜病变、糖尿病黄斑水肿和威胁视力的糖尿病视网膜病变的危险因素。
Asia Pac J Ophthalmol (Phila). 2024 May-Jun;13(3):100067. doi: 10.1016/j.apjo.2024.100067. Epub 2024 May 13.
3
Influence of serum lipids on the incidence and progression of diabetic retinopathy and macular oedema: Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular genetics Study-II.血清脂质对糖尿病视网膜病变和黄斑水肿发病和进展的影响:Sankara Nethralaya 糖尿病视网膜病变流行病学和分子遗传学研究 II。
Clin Exp Ophthalmol. 2017 Dec;45(9):894-900. doi: 10.1111/ceo.12990. Epub 2017 Jun 22.
4
Younger Age and Albuminuria are Associated with Proliferative Diabetic Retinopathy and Diabetic Macular Edema in the South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) Study.在南印度糖尿病视网膜病变遗传学研究(SIGNATR)中,年龄较小和白蛋白尿与增生性糖尿病视网膜病变和糖尿病性黄斑水肿相关。
Curr Eye Res. 2022 Oct;47(10):1389-1396. doi: 10.1080/02713683.2022.2091148. Epub 2022 Aug 5.
5
Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India.印度的糖尿病眼病研究(SPEED)。报告#2. 印度 2 型糖尿病患者的糖尿病视网膜病变及威胁视力的糖尿病视网膜病变的危险因素。
Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S21-S26. doi: 10.4103/ijo.IJO_21_19.
6
Optical Coherence Tomography-Based Prevalence of Diabetic Macular Edema and its Associated Risk Factors in Urban South India: A Population-Based Study.基于光学相干断层扫描技术的印度南部城市糖尿病性黄斑水肿患病率及其相关危险因素:一项基于人群的研究。
Ophthalmic Epidemiol. 2022 Apr;29(2):149-155. doi: 10.1080/09286586.2021.1907846. Epub 2021 Apr 15.
7
Association of mean ocular perfusion pressure and diabetic retinopathy in type 2 diabetes mellitus: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, Report 28).2 型糖尿病患者平均眼灌注压与糖尿病视网膜病变的相关性:Sankara Nethralaya 糖尿病视网膜病变流行病学和分子遗传学研究(SN-DREAMS,报告 28)。
Invest Ophthalmol Vis Sci. 2011 Jun 1;52(7):4592-7. doi: 10.1167/iovs.10-6903.
8
Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.2型糖尿病患者肾功能指标与威胁视力的糖尿病视网膜病变之间的相关性:一项针对印度门诊患者的纵向研究
BMJ Open Diabetes Res Care. 2020 May;8(1). doi: 10.1136/bmjdrc-2020-001325.
9
Magnitude and Determinants of Diabetic Retinopathy Among Indian Diabetic Patients Undergoing Telescreening in India.印度接受远程筛查的糖尿病患者中糖尿病视网膜病变的严重程度及决定因素
Telemed J E Health. 2022 Feb;28(2):176-188. doi: 10.1089/tmj.2021.0019. Epub 2021 May 17.
10
Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study.种族差异对糖尿病视网膜病变的患病率和危险因素:新加坡眼病流行病学研究。
Ophthalmology. 2018 Apr;125(4):529-536. doi: 10.1016/j.ophtha.2017.10.026. Epub 2017 Dec 6.

引用本文的文献

1
Incidence and progression of diabetic retinopathy and blindness in Indonesian adults with type 2 diabetes.印度尼西亚2型糖尿病成年患者糖尿病视网膜病变及失明的发病率与进展情况。
PLoS One. 2025 Aug 29;20(8):e0322093. doi: 10.1371/journal.pone.0322093. eCollection 2025.
2
Optimizing Diabetic Retinopathy Screening at Primary Health Centres in India: A Cost-Effectiveness Analysis.优化印度初级卫生中心的糖尿病视网膜病变筛查:一项成本效益分析。
Pharmacoecon Open. 2025 Apr 10. doi: 10.1007/s41669-025-00572-4.
3
Incidence of Diabetic Retinopathy in Individuals with Type 2 Diabetes: A Study Using Real-World Data.
2型糖尿病患者糖尿病视网膜病变的发病率:一项基于真实世界数据的研究。
J Clin Med. 2024 Nov 23;13(23):7083. doi: 10.3390/jcm13237083.
4
Inhibition of viability of human retinal microvascular endothelial cells by vialinin A under high glucose condition.在高糖条件下,vialinin A对人视网膜微血管内皮细胞活力的抑制作用。
Int J Ophthalmol. 2024 Oct 18;17(10):1809-1815. doi: 10.18240/ijo.2024.10.06. eCollection 2024.
5
Clinical Profile and Ocular Morbidities in Patients with Both Diabetic Retinopathy and Uveitis.糖尿病视网膜病变合并葡萄膜炎患者的临床特征及眼部疾病
Ophthalmol Sci. 2024 Mar 7;4(6):100511. doi: 10.1016/j.xops.2024.100511. eCollection 2024 Nov-Dec.
6
Effect of a self-care promoting program on engagement in self-care behaviors and health-related outcomes among persons with type 2 diabetes and diabetic retinopathy: A single-blind randomized controlled trial.自我护理促进项目对2型糖尿病合并糖尿病视网膜病变患者自我护理行为参与度及健康相关结局的影响:一项单盲随机对照试验。
Belitung Nurs J. 2024 Jun 28;10(3):272-284. doi: 10.33546/bnj.3360. eCollection 2024.
7
Present and future screening programs for diabetic retinopathy: a narrative review.糖尿病视网膜病变的当前及未来筛查项目:一篇叙述性综述
Int J Retina Vitreous. 2024 Feb 3;10(1):14. doi: 10.1186/s40942-024-00534-8.
8
A deep learning system for predicting time to progression of diabetic retinopathy.一种用于预测糖尿病视网膜病变进展时间的深度学习系统。
Nat Med. 2024 Feb;30(2):584-594. doi: 10.1038/s41591-023-02702-z. Epub 2024 Jan 4.
9
Hyperlipidemia and lipid-lowering therapy in diabetic retinopathy (DR): A bibliometric study and visualization analysis in 1993-2023.糖尿病视网膜病变(DR)中的高脂血症与降脂治疗:1993 - 2023年文献计量学研究与可视化分析
Heliyon. 2023 Oct 17;9(10):e21109. doi: 10.1016/j.heliyon.2023.e21109. eCollection 2023 Oct.
10
Developing a Risk Stratification Model Based on Machine Learning for Targeted Screening of Diabetic Retinopathy in the Indian Population.基于机器学习开发风险分层模型以对印度人群进行糖尿病视网膜病变的靶向筛查。
Cureus. 2023 Sep 24;15(9):e45853. doi: 10.7759/cureus.45853. eCollection 2023 Sep.